IFRX•benzinga•
InflaRx Says CHMP of European Medicines Agency Recommends Marketing Authorization Of Gohibic (Vilobelimab) Under Exceptional Circumstances For Treatment Of Adult Patients With Sars-cov-2-induced Acute Respiratory Distress Syndrome Receiving Systemic Corti
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 15, 2024 by benzinga